Target intelligence / Profile preview

Peptidylprolyl isomerase A pseudogene 58 (PPIAP58)

Target
PPIAP58
Molecular classification
Pseudogene, Long non-coding RNA (lncRNA)
01

Overview

Peptidylprolyl isomerase A pseudogene 58 (PPIAP58) is a pseudogene related to peptidylprolyl isomerase A (cyclophilin A)[7]. Unlike the protein-coding gene PPIA (which encodes cyclophilin A, a peptidyl-prolyl cis-trans isomerase involved in protein folding, immune response, and viral infection), PPIAP58 does not encode a functional protein and does not participate directly in biological signaling or disease progression. While other pseudogenes of PPIA have been implicated in non-coding RNA–mediated regulation of the parent gene in cancer[8], there is no evidence that PPIAP58 itself has such a role. It is not considered a therapeutic target, and no drugs are described that act on it. Key distinction: - PPIAP58 is a pseudogene, not a functional gene, receptor, or enzyme. - Do not confuse PPIAP58 (the pseudogene) with PPIA (Cyclophilin A), which is a well-characterized drug target with roles in immunity and infection[2][3]. If you need information about Cyclophilin A (PPIA) as a therapeutic target, refer specifically to "Peptidylprolyl isomerase A (Cyclophilin A)" or "PPIA" rather than pseudogenes like PPIAP58[3][7].

Other names
Peptidylprolyl isomerase A (cyclophilin A) pseudogenePPIAP58
02

Biological functions

Pseudogene (generally lacks protein-coding function)Potential indirect regulation of parent gene expression (if expressed as lncRNA, no direct evidence for PPIAP58)
03

Disease associations

No direct association with diseaseNo established role in disease progression (potential indirect lncRNA role not evidenced for PPIAP58)

Beyond the preview

Go deeper on Peptidylprolyl isomerase A pseudogene 58 (PPIAP58).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 58 (PPIAP58).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call